Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$96.63 +0.92 (+0.96%)
As of: Sep 30, 2026 · 1:23 PM EDT

Rhythm Pharmaceuticals, Inc. (RYTM) Capital Leases (2019 - 2022)

Updated

Rhythm Pharmaceuticals' Capital Leases came in at $1.78 million for Q1 2022, down 26.0% from $2.41 million a year earlier and down 8.4% from the prior quarter.

Analysis

Rhythm Pharmaceuticals, Inc. (RYTM) Capital Leases (2019 - 2022) Analysis & Trends

At the end of FY2021, Rhythm Pharmaceuticals' Capital Leases was $1.95 million, down 23.8% from FY2020.

  • Going back by year, Capital Leases was $2.55 million in FY2020 (-17.3%) and $3.09 million in FY2019.
  • The Q1 2022 figure represents the lowest quarterly Capital Leases in data going back to Q1 2019.
  • Year-over-year, Capital Leases has declined for four consecutive quarters, with an average decline of 20.0% over the last seven quarters.
  • Business Quant data shows RYTM's Capital Leases at $1.95 million (Q4 2021), $2.1 million (Q3 2021) and $2.26 million (Q2 2021) in the three quarters before Q1 2022.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 1.78 Mn
Dec 31, 2021 1.95 Mn
Sep 30, 2021 2.10 Mn
Jun 30, 2021 2.26 Mn
Mar 31, 2021 2.41 Mn
Dec 31, 2020 2.55 Mn
Sep 30, 2020 2.69 Mn
Jun 30, 2020 2.83 Mn
Dec 31, 2019 3.09 Mn
Sep 30, 2019 3.21 Mn
Jun 30, 2019 3.33 Mn
Mar 31, 2019 3.45 Mn
API Access

Rhythm Pharmaceuticals, Inc. Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=RYTM&period=max&api_key=YOUR_API_KEY